A Phase 2 Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200
Conditions: Methamphetamine-dependence; Methamphetamine Abuse Interventions: Drug: IXT-m200; Other: Placebo Sponsors: InterveXion Therapeutics, LLC; National Institute on Drug Abuse (NIDA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials